Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris
- 31 January 2006
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 54 (1) , 73-81
- https://doi.org/10.1016/j.jaad.2005.04.046
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Objective assessment of compliance with treatments in acneBritish Journal of Dermatology, 2005
- Management of AcneJournal of the American Academy of Dermatology, 2003
- A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac®) applied once daily and a clindamycin lotion formulation (Dalacin T®) applied twice daily in the topical treatment of acne vulgarisBritish Journal of Dermatology, 2000
- Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac®) and a proprietary 0.025% tretinoin gel formulation (Aberela®) in the topical control of facial acneJournal of the European Academy of Dermatology and Venereology, 1998
- Clinical efficacy of Velac®, a new tretinoin and clindamycin phosphate gel in acne vulgarisJournal of the European Academy of Dermatology and Venereology, 1998
- Why and When the Treatment of Acne FailsDermatology, 1998
- Efficacy of a fixed clindamycin phosphate 1.2%, tretinoin 0.025% gel formulation (Velac) in the topical control of facial acne lesionsJournal of Dermatological Treatment, 1998
- Patient compliance: Enhancing clinician abilities and strategiesJournal of the American Academy of Dermatology, 1995
- Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: Results of a multicenter, double-blind investigationJournal of the American Academy of Dermatology, 1987
- Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycinAntimicrobial Agents and Chemotherapy, 1982